Recently granted CE Mark, the novel test delivers improved sensitivity and accuracy for faster and more reliable diagnosis in emergencies.The test helps clinicians quickly identify heart attack and ...
The latest upgrade brings the ability to save your progress and create custom agents, with fewer behavioral issues, such as ...
Microsoft today introduced “vibe working” with Agent Mode in Office Apps and Agent Mode in Copilot Chat. The basic premise ...
Bunge Global SA (NYSE: BG) will provide a business update on Wednesday, Oct. 15, prior to the market opening. The update will ...
Ambac Financial Group, Inc., an insurance holding company, today announced it has entered into a definitive agreement to acquire ArmadaCare, a leading supplemental health insurance program manager, ...
MEXICO CITY, Sept. 29, 2025 /PRNewswire/ — FIBRA Prologis (BMV: FIBRAPL 14), a leading owner and operator of Class-A logistics real estate in Mexico, will host a webcast and conference call with ...
The Preferred Shares are expected to begin trading on NYSE American LLC under the ticker symbol “PHXE.P” on Tuesday, ...
When advisors finally reconsider their firm, it is usually because of a push-pull dynamic. The “push” is pain: frustrations ...
Zoho Arattai, a lightweight messenger built for low-end phones and weak networks, saw a 100x traffic spike. Infrastructure ...
Lending momentum continues with 5.0% quarter-on-quarter (QoQ) growth in net loans, while deposit growth slows to 2.8% ...
Detailed price information for Sagimet Biosciences Inc Series A (SGMT-Q) from The Globe and Mail including charting and trades.
BiopharmaCo Profile Upon completion, Biopharma Co will be a clinical-stage biotechnology company focused on the development and potential commercialization of innovative therapeutics for autoimmune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback